Editorial
Volume: 5 | Issue: 2 | Published: Nov 05, 2022 | Pages: 059 - 060 | DOI: 10.24911/JBCGenetics/183-1653668216
Vosoritide: a drug providing a promising avenue for the treatment of short stature in children with achondroplasia
Authors: Amsal Qureshi , Areesha Moiz Alvi
Article Info
Authors
Amsal Qureshi
Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan
Areesha Moiz Alvi
Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Publication History
Received: May 27, 2022
Revised: July 09, 2022
Accepted: October 16, 2022
Published: November 05, 2022
Abstract
Not available
Keywords: Achondroplasia, Vosoritide, FGFR3, children, CNP
